INHIBITION OF MT1-MMP (MMP14) IMPROVES ANT-GLIOMA EFFECT OF COMBINATION: TEMOZOLOMIDE-IONIZING RADIATION IN THE GLIOBLASTOMA CANCER CELLS
https://doi.org/10.17650/1726-9784-2015-14-2-53-58
Abstract
The main goal of our study is to provide clinical and biological assessment of MMP14 as gene that causes recurrent glioblastoma. We analyzed expression of MMP14 in 108 and 129 samples represented by Rembrandt 8РOncomine databases. The biological significance was done is based on genetic knockdown and rescuing of MMP14 attenuated U87 and U251 glioma cells followed by cytofluorimetry and array gene expression. As expected, genetic silencing of MMP14 led to accumulation cells in the “G2” phase of cell divisions which correlates to cell kinase’s expression. Furthermore, exposure of MMP14 to ionizing radiation and temozolomidt treatments prolongs glioma cell proliferation and increase the anti-glioma effect of temozolomide-ionizing radiation therapeutic combination. Our data suggest that most of the neoplastic glioma cells express significantly MMP14.Therefore, alteration of MMP14, improves anti-tumor effect.
About the Authors
I. V. Ulasov
Центр опухолей головного мозга, Шведский медицинский центр; ФГБНУ «РОНЦ им Н.Н. Блохина»
Russian Federation
Russian Federation
N. V. Kaverina
ФГБНУ «РОНЦ им Н.Н. Блохина»
Russian Federation
Russian Federation
Z. G. Kadagidze
ФГБНУ «РОНЦ им Н.Н. Блохина»
Russian Federation
Russian Federation
A. Y. Baryshnikov
ФГБНУ «РОНЦ им Н.Н. Блохина»
Russian Federation
Russian Federation
References
1. Брюховецкий И.С., Брюховецкий А.С., Мищенко П.В., Хотимченко Ю.С. Роль системных механизмов миграции и хоуминга стволовых клеток в развитии злокачественных опухолей центральной нервной системы и разработка новых методов противоопухолевой терапии // Российский биотерапевтический журнал. - 2013. - Т. 12, № 4. - С. 3-12.
2. Степанова Е.В., Зейналова К.Р. Механизмы резистентности к трантузумабу // Российский биотерапевтический журнал. - 2011. - Т. 10, № 4. - С. 3-8.
3. Уласов И.В., Каверина Н.В., Кадагидзе З.Г., Барышников А.Ю. Антиглиомная аденовирусная виротерапия: механизм, регуляция и клинические перспективы // Российский биотерапевтический журнал. - 2014. - Т. 13, № 2. - С. 11-8.
4. Banerjee N.S., Rivera A.A., Wang M. et al. Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures // Mol Cancer Ther. - 2004. - 3(4). - P. 437-49.
5. Fernandez-Vidal A., Ysebaert L., Didier C. et al. Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia // Cancer Res. - 2006. - 66(14). - P. 7128-35.
6. Groves M.D., Puduvalli V.K., Hess K.R. et al. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme // J Clin Oncol. - 2002. - 20(5). - P. 1383-8.
7. Hagemann C., Anacker J., Ernestus R.I., Vince G.H. A complete compilation of matrix metalloproteinase expression in human malignant gliomas // World J. Clin. Oncol. - 2012. - 3(5). - P. 67-79.
8. Kim J.H., Bae Kim Y., Han J.H. et al. Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases // Am. J. Surg. Pathol. - 2012. - 36(4). - P. 620 8.
9. Lehti K., Allen E., Birkedal-Hansen H. et al. An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature // Genes Dev. - 2005. - 19(8). - P. 979-91.
10. Levin V.A., Phuphanich S., Yung W.K. et al. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation // J Neurooncol. - 2006. - 78(3). -P. 295-302.
11. Li R., Li G., Deng L. et al. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1 // Oncol Rep. - 2010. - 23(6). - P. 1553-9.
12. Ulasov I., Yi R., Guo D. et al. The emerging role of MMP14 in brain tumorigenesis and future therapeutics // Biochim Biophys Acta. - 2014. - 1846(1). - P. 113-20.
13. Saini D., Shelke S., Mani Vannan A. et al. Transcription profile of DNA damage response genes at G(0) lymphocytes exposed to gamma radiation // Mol Cell Biochem. - 2012. - 364(1/2). - P. 271-81.
14. Ulasov I., Thaci B., Sarvaiya P. et al. Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas // Cancer Med. - 2013. -2(4). - P. 457-67.
15. Wang H., Wang S., Shen L. et al. Chk2 down-regulation by promoter hypermethylation in human bulk gliomas // Life Sci. - 2010. - 86(5/6). - P. 185-91.
Review
For citations:
Ulasov I.V., Kaverina N.V., Kadagidze Z.G., Baryshnikov A.Y. INHIBITION OF MT1-MMP (MMP14) IMPROVES ANT-GLIOMA EFFECT OF COMBINATION: TEMOZOLOMIDE-IONIZING RADIATION IN THE GLIOBLASTOMA CANCER CELLS. Russian Journal of Biotherapy. 2015;14(2):53-58. (In Russ.) https://doi.org/10.17650/1726-9784-2015-14-2-53-58
Views:
317
Email this article 
